Suppr超能文献

2019冠状病毒病患者的全球死亡率患病率及决定因素:一项系统评价和荟萃分析。

Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis.

作者信息

Abate Semagn Mekonnen, Checkol Yigrem Ali, Mantefardo Bahiru

机构信息

Department of Anesthesiology, College of Health Sciences and Medicine, Dilla University, Dilla, Ethiopia.

Department of Mental Health and Psychiatry, College of Health Sciences and Medicine, Dilla University, Dilla, Ethiopia.

出版信息

Ann Med Surg (Lond). 2021 Apr;64:102204. doi: 10.1016/j.amsu.2021.102204. Epub 2021 Mar 4.

Abstract

BACKGROUND

The challenge of COVID-19 is very high globally due to a lack of proven treatment and the complexity of its transmission. The prevalence of in-hospital mortality among patients with COVID-19 was very high which ranged from 1 to 52% of hospital admission. The prevalence of mortality among intensive care patients with COVID-19 was very high which ranged from 6% to 86% of admitted patients.

METHODS

A three-stage search strategy was conducted on PubMed/Medline; Science direct Cochrane Library. The Heterogeneity among the included studies was checked with forest plot, χ2 test, I2 test, and the p-values. Publication bias was checked with a funnel plot and the objective diagnostic test was conducted with Egger's correlation, Begg's regression tests.

RESULT

The Meta-Analysis revealed that the pooled prevalence of in-hospital mortality in patients with coronavirus disease was 15% (95% CI: 13 to 17). Prevalence of in-hospital mortality in patients with COVID-19 was strongly related to different factors. Patients with Acute respiratory distress syndrome were eight times more likely to die as compared to those who didn't have, RR = 7.99(95% CI: 4.9 to 13).

CONCLUSION

The review revealed that more than fifteen percent of patients admitted to the hospital with coronavirus died. This presages the health care stakeholders to manage morbidity and mortality among patients with coronavirus through the mobilization of adequate resources and skilled health care providers.

REGISTRATION

This systematic review and meta-analysis was registered in research registry with UIN of reviewregistry1093.

摘要

背景

由于缺乏经过验证的治疗方法及其传播的复杂性,新型冠状病毒肺炎(COVID-19)在全球范围内带来了巨大挑战。COVID-19患者的院内死亡率很高,在入院患者中占1%至52%。COVID-19重症监护患者的死亡率很高,在入院患者中占6%至86%。

方法

在PubMed/Medline、Science direct和Cochrane图书馆进行了三阶段检索策略。使用森林图、χ²检验、I²检验和p值检查纳入研究之间的异质性。使用漏斗图检查发表偏倚,并使用Egger相关性检验、Begg回归检验进行客观诊断测试。

结果

Meta分析显示,冠状病毒病患者的院内死亡率合并患病率为15%(95%置信区间:13%至17%)。COVID-19患者的院内死亡率与不同因素密切相关。与没有急性呼吸窘迫综合征的患者相比,患有急性呼吸窘迫综合征的患者死亡可能性高8倍,相对危险度RR = 7.99(95%置信区间:4.9至13)。

结论

该综述显示,超过15%的因冠状病毒入院的患者死亡。这预示着医疗保健利益相关者需要通过调动充足的资源和熟练的医疗保健提供者来管理冠状病毒患者的发病率和死亡率。

注册情况

本系统评价和Meta分析已在研究注册库中注册,注册号为reviewregistry1093。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e558/7972969/81f4c84c5743/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验